JOHN J. MONAHAN - 05 Jan 2026 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Role
Director
Signature
/s/ John J. Monahan
Issuer symbol
TOVX
Transactions as of
05 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 16:54:19 UTC
Previous filing
01 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MONAHAN JOHN J Director C/O THERIVA BIOLOGICS, INC., 9605, MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE /s/ John J. Monahan 06 Jan 2026 0001257825

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOVX Stock Options (right to buy) Award $0 +75,000 $0.000000 75,000 05 Jan 2026 Common Stock 75,000 $0.2410 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest pro rata on a monthly basis over 12 months.